SANTA CLARA, Calif., Oct. 18, 2005 (PRIMEZONE) -- At the 10th World Congress on Advances in Oncology and 8th International Symposium on Molecular Medicine, held October 13-15, 2005 in Crete, Greece, scientists with the Dr. Rath Research Institute revealed a new study that shows cancer metastasis can be stopped in mice using a combination of nutrients.
The research marks the first time that nutrient synergy had been shown to stop the invasion of cancer to other organs (metastasis) in vivo (i.e., in the body of a living organism). Previously, the Dr. Rath Research Institute had published studies showing that metastasis of various cancers can be stopped in vitro. Metastasis is the spread of cancer from its primary site to other places in the body. It is this process that makes cancer such a potentially life-threatening disease.
The Research Institute was invited to present its study, entitled "Inhibitory effect of a novel mixture containing ascorbic acid, lysine, proline and green tea extract on critical parameters in cancer progression," during a session of the conference devoted to chemoprevention and pharmacology.
The announcement was made on the heels of a study by the U.S. National Institutes of Health, which strongly confirmed that vitamin C has the potential to fight cancer when injected intravenously in high dosages. The Dr. Rath Research Institute study is based on a concept developed by Matthias Rath, M.D. defining the critical role of vitamin C together with an amino acid, lysine, in the control of cancer growth and spread. The institute's published research results document that vitamin C, used in combination with the amino acids L-lysine, L-proline and a polyphenol fraction of green tea known as Epigallocatechin Gallate (EGCG), could not only kill cancer cells, but significantly limit tumor growth, its infiltration by blood vessels (angiogenesis), and completely stop the invasion and spread of more than two dozen cancer cell types.
"A growing number of researchers confirm that Dr. Rath was right, and nutrients, especially when used in a synergy, can control all critical stages of cancer," said Aleksandra Niedzwiecki, Ph.D., director of research at the institute, who presented the findings at the conference. The conference was organized by Demetrios A. Spandidos, professor of virology at the Medical School, University of Crete, who personally invited the Dr. Rath Research Institute to the event. The Dr. Rath Research Institute is calling for a radical change in the therapeutic approach to cancer, one that takes advantage of new natural approaches. Conventional approaches, such as highly toxic chemotherapy and radiation, have been unsuccessful in curing the disease; have contributed only to the accelerated cost of health care and led to the development of new diseases resulting from the side effects of these treatments.
The Dr. Rath Research Institute offers innovative, safe, effective and natural solutions to cancer. To learn more, visit www.drrathresearch.org.